Skip to content

Establishment of a prospective cohort of pregnant women with gestational diabetes mellitus in Hainan Province and a predictive model for adverse perinatal outcomes

Establishment of a prospective cohort of pregnant women with gestational diabetes mellitus in Hainan Province and a predictive model for adverse perinatal outcomes

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059281
Enrollment
Unknown
Registered
2022-04-28
Start date
2022-01-01
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes

Interventions

Case group:None

Sponsors

Hainan General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old; 2. Pregnancy diabetes: 1)FPG=5.1mmol/L 2) 1h blood glucose = 10.0mmol/L; 3) The diagnosis can be made if the blood glucose = 8.5mmol/L in 2h. Or at any time during pregnancy, the OGTT results in accordance with the Guidelines for the Prevention and Treatment of Type 2 diabetes in China (2017) formulated by the diabetes Branch of the Chinese Medical Association are consistent with the diagnosis of GDM or dominant diabetes during pregnancy. 3. It is planned to receive standardized prenatal examination, pregnancy health care, production and post-natal care in this institution or research cooperation institution; 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Definitely diagnosed as any type of diabetes in the past; 2. diabetes caused by glucocorticoid use; 3. Complicated with serious systemic diseases and malignant tumors; 4. In a state of stress such as infection and trauma; 5. Complicated with serious mental illness and cognitive impairment; 6. Unable to cooperate independently to complete the examination and follow-up related to the study; 7. Participate in other clinical trials within three months before enrollment.

Design outcomes

Primary

MeasureTime frame
General clinical data;glucose metabolism;Lipid metabolism;Routine blood;liver function;renal function;electrolyte;

Countries

China

Contacts

Public ContactHaiwei Liu

Hainan General Hospital

15208981757@163.com+86 898 68642114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026